FULGENT GENETICS, INC. Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax
FULGENT GENETICS, INC. (FLGT) reported Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax · last filed 2026-07-30
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-06-30 was $0.00.
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2026-03-31 was $0.00.
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-06-30 was $0.00.
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for the quarter ending 2025-03-31 was $0.00.
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2025 was $0.00.
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2024 was $0.00.
- FULGENT GENETICS, INC. other comprehensive income (loss), foreign currency translation adjustment, tax for fiscal 2023 was $0.00.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax 12 month |
|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-01 | ||
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | ||
| 2025-06-30 | $0.00 10-Q · filed 2026-07-30 | $0.00 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-01 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |